Clinical Trials

36 studies in Gastroenterology and Hepatology - Minnesota

  1. Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
    1. Minnesota
  2. Observational Study of Persons With Hepatitis B Virus Infection in North America (Cohort Study)
    1. Minnesota
  3. Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis - A Human Pilot Study
    1. Minnesota
  4. A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
    1. Minnesota
  5. A Phase II Trial of Temsirolimus and Bevacizumab in Patients With Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid or Islet Cell Cancer
    1. Arizona
    2. Minnesota
  6. Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry
    1. Minnesota
  7. Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in HBeAg-positive and HBeAg-negative Chronic Hepatitis B
    1. Minnesota
  8. A Randomized Placebo-Controlled Trial of Montelukast in Maintenance Therapy of Asymptomatic Eosinophilic Esophagitis
    1. Minnesota
  9. Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease
    1. Arizona
    2. Florida
    3. Minnesota
  10. Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index: A Prospective Multicenter Study
    1. Arizona
    2. Florida
    3. Minnesota
  1. Prev
  2. 1
  3. 2
  4. 3
  5. 4
  6. Next

Clinical Trials

36 studies in Gastroenterology and Hepatology - Minnesota

  1. Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
    1. Minnesota
  2. Observational Study of Persons With Hepatitis B Virus Infection in North America (Cohort Study)
    1. Minnesota
  3. Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis - A Human Pilot Study
    1. Minnesota
  4. A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
    1. Minnesota
  5. A Phase II Trial of Temsirolimus and Bevacizumab in Patients With Endometrial, Ovarian, Hepatocellular Carcinoma, Carcinoid or Islet Cell Cancer
    1. Arizona
    2. Minnesota
  6. Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry
    1. Minnesota
  7. Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in HBeAg-positive and HBeAg-negative Chronic Hepatitis B
    1. Minnesota
  8. A Randomized Placebo-Controlled Trial of Montelukast in Maintenance Therapy of Asymptomatic Eosinophilic Esophagitis
    1. Minnesota
  9. Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease
    1. Arizona
    2. Florida
    3. Minnesota
  10. Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index: A Prospective Multicenter Study
    1. Arizona
    2. Florida
    3. Minnesota
  1. Prev
  2. 1
  3. 2
  4. 3
  5. 4
  6. Next
.

Mayo Clinic Footer